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Abstract Digital healthcare information systems promise to

improve care efficiency, to reduce complexity for patients, and
to increase access to information and advance research efforts.
A prominent example are multi-sided-platforms (MSP), which
are essentially an information business, linking key healthcare
stakeholders for individualized as well as aggregated information
services. However, platform-based health innovation relies on
the extensive collection, storage, and use of sensitive health
information, raising issues of information privacy. This study
uses the privacy calculus perspective to shed light on patients’
trade-off considerations. We use the case of a MSP, which
connects patients, care providers and researchers, in order to
model a multi-level calculus for health information of terminally
ill patients. These insights inform stepwise consent options,
which highlight the trade-offs between information value and
patient privacy. By reflecting on the implications for patient
empowerment this conceptual paper develops a research agenda
on how to study and design responsible health information
systems.

DOI https://doi.org/10.18690/978-961-286-362-3.2
ISBN 978-961-286-362-3

Keywords:
healthcare
multi-sided
platform,
privacy
calculus,
patient
empowerment,
terminal
illness,
rare
diseases.

33RD BLED ECONFERENCE
ENABLING TECHNOLOGY FOR A SUSTAINABLE SOCIETY

22

1

Introduction

The delivery of healthcare and disease management are information intensive fields,
in which the effective exchange of sensitive information is a crucial success factor.
Digital technologies have started to transform healthcare worldwide based on
promises of decreased costs and improved quality. Digital multi-sided platforms
(MSP) act as intermediaries between different stakeholders such as patients,
providers and purveyors (Davidson et al., 2018; Hagiu and Wright, 2015). Especially
in light of severe neurological diseases like amyotrophic lateral sclerosis (ALS),
healthcare providers struggle to keep up with the pace of the progressing symptoms
and patients’ increasing need for care, therapeutic interventions, assistive
technologies, and medication (Funke et al., 2015). Here, MSP create new possibilities
to promote a patient-centric model of care delivery and at the same time cut costs
(Kuziemsky and Vimarlund, 2018). Several studies suggest that the use of
information systems can enhance patient empowerment (Risling et al., 2017, Angst
and Agarwal 2004, Deng et al., 2013).
However, there is a promise-delivery gap concerning technology and data driven
improvement of healthcare. In order to close the gap, challenges and wider
implications for all stakeholders need to be considered (Davidson et al., 2018).
Platform-based healthcare innovation claims are premised on the centralization,
access and efficient use of large amounts of sensitive information. Thus, information
privacy is becoming a critical topic involving perplexing trade-offs for patients: They
have to weigh promises of sharing information against the potential risks and
concerns related to losing control over their information (Laufer and Wolfe, 1977;
Culnan and Armstrong, 1999). The sharing of medical information is not limited to
impacting individuals only but yields promises to advance public health research
efforts of profound societal relevance. In the context of ALS, data driven care
studies appear to be particularly promising as the disease is rare (about 1% of the
population are affected) and without any known cure. In addition to progressing the
body of medical knowledge, direct impact of research efforts for the patient
community can be expected. Ethical discourses evolve around data donations and
the question whether medical data should be considered a common good (Hummel
et al., 2019).
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While benefits of using large amounts of medical data to foster innovation, increase
efficiencies or improve medical and care research become apparent, they must be
balanced with protecting personal privacy. The issue of information exchange on a
healthcare platform has rarely been examined from a patient perspective and with
respect to patient sovereignty and empowerment (Shen et al., 2019). The purpose of
this research is thus to use the privacy calculus perspective in order to illustrate the
dilemmas of terminally ill patients in the context of a healthcare MSP. More
specifically it will address the question: (How) is it possible to balance information needs and
patient privacy, while ensuring patients’ empowerment?
This research will examine multiple trade-offs that arise from patients’ perspectives
on numerous information purposes from a privacy calculus perspective. Our
empirical setting is Ambulanzpartner Soziotech GmbH (APST), a MSP that
orchestrates case management for severe neurological diseases. APST acts as an
intermediary between patients and care providers, and thus as information
aggregator, guardian and gatekeeper (Fürstenau et al. 2019). It also collects and uses
information for research purposes. Based on a rich case description we first shed
light on the particularities of the healthcare MSP and its information centric
practices. Focusing on the patient’s perspective, privacy calculus theory is used as
lens on the value of personal health information. We have used an extreme case
sampling strategy to select the case, expecting that it will yield more clearly articulated
views on privacy trade-offs. We propose exemplary design options that have the
potential to enhance patients’ information sovereignty and meet information needs
appropriately. Finally, we will discuss relevant implications and provide an outlook
for empirical investigations.
Our contributions are twofold: First, we contribute to the information privacy
literature by enhancing the understanding of terminally ill patients’ privacy
perceptions in a digital healthcare context. We explore possible contingency factors
that extend the privacy calculus in this realm. Second, we inform the design of a
stepwise consent option that paves the way for an informed calculus. We further
discuss and reflect on implications of platform-based information exchange in
healthcare for patient empowerment to enable responsible healthcare innovation.
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2

Case Background

We use an extreme case to examine data-based healthcare management 1. The
operating logic of APST and the nature of information exchange via the healthcare
MSP provide a backdrop for a deeper understanding of the trade-offs that patients
face.
2.1

Platform-based Innovation for ALS Care

ALS is considered a “relentlessly progressive and fatal neurodegenerative disease
characterized by progressive weakness of voluntary muscles of movement as well as
those for swallowing, speech and respiration” (Soriani and Desnuelle 2017, p. 288).
Due to the severity and swift progression of the symptoms, patients are not only
overwhelmed by the dire prognosis of a non-curable disease, but face challenges of
organizing and adjusting medical care and assistive technology as the disease
progresses. Thus, ALS care has profound ethical issues during treatment and care
(for a review, see Seitzer et al. 2016). One of the several shortcomings in the German
ALS Care System is the significant delay of providing assistive technology due to
long insurance approval processes (Funke et al., 2015). APST aims to address these
gaps and provides an illustration of how a digital health platform can facilitate the
coordination and inter-professional cooperation of multiple providers as a multisided transaction platform model. APST is operating under two different logics:
providing care management on the one hand and functioning as research
infrastructure on the other. By maintaining the electronic health record and
connecting patients and doctors with care providers and assistive technology
providers, the platform aims to transform the field to a new way of care
orchestration. Opportunities are created that lead not only to complexity reduction
for individual patients but also promise an increase in efficiency and effectiveness of
care provision (Fürstenau et al., 2018). Patient feedback on care services and devices
is solicited in order to improve the quality of care and faciltiate a learning cycle. At
the same time, the platform is connecting the patient pool with research partners to
conduct medical and care studies or improve platform efficiency. Thus, the
disclosure of personal health information holds not only potential benefits for the
Based on purposeful sampling and extreme case selection (Yin, 2009) we investigate a rare and terminal disease.
The distinctive setting of a disease with no known cure functions as a magnifying glass to patient’s perceptions and
reveals specificities of risk and benefit perceptions that emerge and manifest themselves in a more pronounced way
in this context.

1
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orchestration of patients’ care but also for the platform and the related partners
(service providers and researchers).
2.2

Information as Main Resource

Innovative modes of interaction are possible because of patient’s health and medical
information: As a digital intermediary, which collects, stores and redistributes
information, APST relies on the extensive use and economization of patient data.
APST thus combines the data-economy logic of information accumulation with the
goal of providing a patient-centric care model. This raises potential conflicts of
interest as it takes practices critically discussed in the context of data capitalism
(Zuboff, 2019) to the realm of care. For APST, patient information is one of the
main resources. Drawing on Levitan (1982), we depicted the information lifecycle
for APST in Figure 1.

Figure 1: APST Information Resource Lifecycle
(adapted from Levitan, 1982, p. 48)

Information is acquired and generated by patients who provide personal information
or a health record to the platform, give feedback or respond to surveys and take part
in trials. By storing it centrally, APST is able to transform and prepare the
information for further purposes. The different modes of interaction and the
different stakeholders that are involved are illustrated by the flow of information via
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information products to the various users. The information lifecycle sheds light on
the dynamics that arise with information as the main resource from the perspective
of APST and illustrates the diverse purposes and types of use for collected
information. Patient information, which is provided by consenting patients, is
essential for a successful operation of the platform. Empowering patients to make
informed choices about providing information is crucial in order to ensure that
APST is not only extracting value from the information but also – and primarily creating value that will benefit patients. It is therefore crucial to understand how
patients reach the decisions to consent and to share. We take the patients’
perspective and model trade-offs initially within the parameters of the case before
discussing options of generalizability.
3

Health Privacy Calculus of Terminally Ill Patients

3.1

Related Work

Information privacy has triggered a significant stream of interdisciplinary research
(Smith et al., 2011). Due to the sensitive nature of relationships it has been a longrecognized issue in healthcare. Health information privacy research that addresses
the patient’s perspective has mainly considered concerns (Rindfleisch, 1997), risk
perceptions, and information sensitivity which were found to influence the adoption
of electronic health records (EHR) among others (Angst and Agarwal, 2009). The
privacy calculus was introduced to social sciences by Laufer and Wolfe (1977).
Following elaborations by Culnan and Armstrong (1999) it was refined and extended
in order to explain how online users weigh privacy related risks against benefits, and
became a prominent topic in IS research (Dinev and Hart, 2006). The examination
of trade-offs has also been applied to health-related decisions (Dinev et al., 2016).
Health information is perceived as having the highest risk profile compared to other
personal data, when sharing decisions are considered (Milne et al., 2017). Next to
information sensitivity, health information privacy concerns that address the use,
collection, and access to information play a major role (Kenny and Connolly, 2016).
To mitigate the effects of risk as a major inhibitor, control and trust are discussed.
Perceived benefits and promises that are tied to the information sharing can
compensate the perceived risks. Convenience, internet experience or personal
factors (like emotions) were proposed to influence the calculus and attitudes of
patients (Anderson and Agarwal, 2011; Dinev et al., 2015). We use the lens of the
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privacy calculus to develop a better understanding of privacy trade-offs in
interorganizational relationships from the perspective of the data subject.
3.2

Patient’s Privacy Trade-Off

Following we take the perspective of the ALS patient to examine and sketch out the
relevant considerations in consent situations regarding APST. Perceived risks and
benefits depend on the purpose of information usage. Thus, we distinguish between
the main purposes or information products, as elaborated in the information
lifecycle, to model the trade-offs that arise. In Table 1, type (1-10) and purpose of
information (A-E), are tied to promises that a consent would yield, followed by
potential risks. We model the perceptions based on publicly available information
from APST, most is inferred from the data protection declaration (APST, 2020).
APST makes potential benefits (promises) related to different information purposes
tangible for the patient. Also, secondary benefits like hopes for improvement for
future patients, that do not directly relate to the individual patient, are likely to play
a role. The table suggests that benefits can be tied to type of information and
purpose, while this is not obvious for risks. Privacy valuations are sensitive to
contextual and non-normative factors (Acquisti et al., 2013). The special context of
ALS calls for distinct considerations: As ALS is a rare disease, additional information
for research (D, E) is even more valuable. This however also gives rise to additional
risks: with a small sample, the risk of deanonymization is higher. Patients with special
and immediate care needs tend to be more interested in necessary care transactions
than in concerns about their privacy (Lafky and Horan, 2011). This is presumably
the case for ALS patients as the disease manifests quickly. The risk of leaking
information to employers or others becomes irrelevant as soon as the disease
becomes manifest and insurance providers are inevitably informed once they need
to approve aid. Patients emotional responses might also play a role as it was indicated
that altruistic perceptions can outweigh risks (Spencer et al., 2016).
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Table 1: Privacy calculi of APST patients

Patient
Information
1 Contact
information,
2 physician,
care
providers
3 insurance
information,
4 social
profile,
5 health
record,
6 care and
aid
information,

anonymized
7 survey
responses,
8 feedback
about
assistive
device or
care,
9 care
studies
10 medical
trials/
studies
11
patient
specific
information

Purpose of
information
for APST

Patients' Potential Benefits
Tangible

Secondary

Patients' Privacy
Concerns and
Risks
a) Leakage,

A Care
management

Free usage of
platform,
care provision and
case management

Reduced
complexity for
relatives

B Improving
care, process
efficiency

Better and faster
care, improved
insurance
management

Benefits of
collective
information
sharing, funding
for the platform

C Feedback/
evidencebased care
and aid
assessment
and
improvement

Care providers can
take feedback into
account, overview
over rating on
website,

Improved care and
aid technology
over time and for
future patients,
platform funding

D Care
research

Advanced body of
knowledge that can
improve individual
condition

better care for
future patients,
public health
improvement

f)

deanonymizat
ion,
(dependent
on statistical
parameters of
the patient
sample),

E Medical
research

individualized
treatment (medicine,
assistive devices)

medical progress,
solidarity and
altruistic behavior
as motivator

g)

risk
perception of
IT
infrastructure
(cloud
services,
hosting),

b)

c)
d)

e)

concern
about
inappropriate
use,
uncertainty
about future
use,
uncertainty
about
information
use and
protection by
platform
partners
possibilitiy of
de- and recontextualizat
ion
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Another boundary condition to consider is trust: while APST aims to create a
trustworthy environment, the complexity of the relationships orchestrated by the
paltform can lead to misspecifications of trust (Möhlmann and Jarvenpaa, 2019). By
drawing on relevant literature as well as the parameters of the case, we conjecture
that terminally ill patients perceive higher benefits from sharing information.
4

Towards an Informed Consent Calculus

4.1

The Consent Dilemma

Terminally ill patients depend on efficient and effective orchestration of healthcare.
In order to receive care, information exchange with doctors and caregivers is
inevitable. In situations of advanced care needs, however, the patient is typically
under enormous emotional strain, left with no time nor meaningful decision rights.
This stands in stark contrast to the assumptions of economic rationality underlying
the privacy calculus, as patients will most likely not be able to actually fully assess
risks and benefits. Promises or benefits are most often tangible, while risks are
delayed and hard to grasp (Acquisti et al., 2015). APST has addressed both, legal
requirements and the aim to provide transparency to patients, with an extensive
privacy policy, which needs to be signed by all stakeholder (APST, 2020). However,
research has shown that privacy policies are often neither understood nor read,
instead they may increase information asymmetries. Therefore, users’ need to
consent to conditions they are not able to comprehend creates a consent dilemma
(Solove, 2012). It thus seems crucial to effectively empower patients in the context
of a healthcare MSP, so that they understand the implications of their options as
prerequisite for an informed and meaningful privacy calculus.
4.2

A Stepwise Consent Model

By proposing an exemplary stepwise, and dynamic option for consent we aim to
illustrate how patients can be empowered to apply an informed mental calculus in
the context of APST. Dynamic consent has been discussed in medical research for
means of ethically gathering data for clinical trials (Spencer et al., 2016). Through
legal advancements, dynamic consent has found its way into cookie consent
management. We apply this approach to examine how a consent situation can be
created that integrates the calculus and enables the patient to make an educated
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decision. In Table 2, we depict a possibility to manage information provision consent
for APST in a similar fashion. We translate the findings from Table 1 and Figure 1
in order to establish a consent option, that allows to differentiate between type of
information and different purposes. We have developed one of the hypothetical
consent options to share aid and medical data for information types 6, 9 and 10.
Table 2: Illustration of Consent Options
Your consent options
Your
Information

6 care & aid
information
9
care
studies
10 medical
trials

collection
and use
of transactional
information

sharing
of transactional
information

x

analysis
of anonymized
information

sharing of
anonymized
information
with care
research
partners

x

x

x

x

x

x

x

x

analysis
of
personal
information

sharing of
anonymize
d
informatio
n with
medical
research
partners

Show information:
Information about you, your care and aid prescriptions, usages, provider
and physician information is neccessary to perform a transaction. For a
transaction, we only share the minimum of relevant information needed.
You can choose to provide this data in personalized or anonymized form
for further analysis which helps to improve care efficiency, or provide it
to relevant research efforts to advance care and medical research

We draw on psychological empowerment to inform this option further.
Psychological empowerment is based on the concepts of autonomy, self-efficacy,
meaning and impact (Spreitzer, 1995), which are reflected in patient empowerment
(Bravo et al., 2015, McAllister et al., 2012). The options to decide for which purpose
and in which form patient information is used, would enable patients to make
informed and differentiated choices about sharing information. A consent option
like the one depicted would illustrate the data driven logic of the platform. With a
comprehensive overview, patients are presumably more capable to assess the impact
of information sharing. We could better inform patients’ privacy calculus by
providing the information necessary to make a good judgement of personal risks
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and benefits. We try to address uncertainty about future use by providing an
overview over a range of possible purposes. In this way, we make the information
lifecycle transparent for the patient. Being provided with further details on the
consent decision, patients would not only have more control and autonomy in their
privacy decision making but also understand the impact of their choice which enable
them to attribute meaning to their consent. As privacy preferences are also not stable
but evolving, it would be useful to apply this consent form dynamically. With the
options to make convenient and economic choices we thus aim at patients’
psychological empowerment.
5

Discussion, Limitations and Outlook

In the consent context of the case, patients act as active information contributors.
By providing stepwise and dynamic consent, the patients’ ability to make informed
decisions is extended. She is now able to choose if, how, and to whom power over
personal information is transferred. Acting in the patients’ interest, APST thus takes
on the role as an information trustee. By taking into account individual preferences,
information provision can therefore be considered an exercise of sovereignty
(Hummel et al., 2019). Still it needs to be critically assessed, if privacy in a data driven
business model can truly be balanced in this way. It is conceivable, that reactance
behavior is triggered and patients, as a matter of principle, have higher cautions for
privacy and choose not to share information at all. Patients potentially react the same
way as consumer who scrolls through software update notifications, leading to
higher information asymmetries and a privacy apathy instead of information
sovereignty (Hargittai and Marwick, 2016). In turn we argue that the problem of
patient information overload can be mitgiated by structuring the decisions and
presenting them in a way that faciltiates information consent, thus making it a design
issue. A clear limitation is that we merely provide an exploration based on the
theoretical as well as the case background and can not empirically validate
perceptions and consent options. The rich theoretical background and the specific
case insights, however, pave the way for this empirical examination of patients’
privacy calculus towards a multi-level use of information on a healthcare platform.
Further examination is needed to investigate the differences in perceptions and
valuations, to see, how they relate to the different usages of information on the
platform. In this way, the options that we modeled in chapter four need to be refined
and empirically validated. This paper provides a hypothetical form of enhanced
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consent and further research needs to show how this leads to an increase in
perceived empowerment. A first step would be to explore patients’ privacy
perceptions under the calculus framework. Modelling these valuations into the
consent options, psychological trade-offs that are considered between the different
options could be assessed. To do so, we propose a conjoint analysis. Thus, we will
also be able to examine the relative importance of different bundles of options to
truly understand what terminally ill patients perceive as empowering.
6
Conclusion
We have shed light on the dynamics of a healthcare MSP, which strives on various
categories of patient information (see table 1) as main resource. Adapting the
information lifecycle we show how the platform is drawing on a logic of
accumulation, feedback based-learning and cautious monetization typical for
business models in the data economy, yet with the explicit goal to improve patient
care, care research, and medical research and thus create value for patients.
Information intensive practices incur considerable privacy concerns. We provide
insights in the distinct perspective of terminally ill patients’ privacy perceptions and
decision making. This understanding opens up possibilities to enhance a patientcentered design in the light of a severe neurological disease. We propose a stepwise
consent form to inform meaningful privacy options and to empower patients that
interact with the healthcare platform. This provides an avenue for further empirical
examination of patient empowerment that balances platform innovation, care, and
medical research with information privacy. In this way, our research further
contributes to the advancements of responsible and sustainable healthcare
innovation and research practices.
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